Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Approaches to developing new anxiolytics and antidepressants

S L Dubovsky1

  • 1Department of Psychiatry, University of Colorado School of Medicine, Denver.

The Journal of Clinical Psychiatry
|May 1, 1993
PubMed
Summary

Discovering new anxiety and depression treatments is shifting from trial-and-error to targeted neurobiology. This approach uses specific molecular targets for more precise and effective mood disorder medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive graviton as a testable cold-dark-matter candidate.

Physical review letters·2005
Same author

Rapid cycling bipolar disease: new concepts and treatments.

Current psychiatry reports·2001
Same author

Nicardipine improves the antidepressant action of ECT but does not improve cognition.

The journal of ECT·2001
Same author

Treatment resistance in anxiety disorders.

Bulletin of the Menninger Clinic·2000
Same author

Statistics of clustering of ultrahigh energy cosmic rays and the number of their sources.

Physical review letters·2000
Same author

Are antidepressants addictive?

Health news (Waltham, Mass.)·2000

Area of Science:

  • Neurobiology
  • Psychopharmacology
  • Drug Discovery

Background:

  • Traditional anxiety and depression treatments rely on empirical screening of compounds.
  • This method involves testing numerous drugs similar to existing ones to find better side effect profiles.
  • Advances in neurobiology enable a more precise, mechanism-based approach to treatment development.

Purpose of the Study:

  • To review neurobiologically informed strategies for developing novel anxiety and depression medications.
  • To discuss innovative treatments emerging from a targeted, molecular approach.

Main Methods:

  • Review of current neurobiological knowledge relevant to mood regulation.
  • Identification of specific molecular targets for therapeutic intervention.
  • Analysis of emerging drug candidates based on neurobiological principles.

Main Results:

  • Development of targeted treatments for anxiety and depression is feasible.
  • Examples include specific benzodiazepine receptor agonists and modulators of neurotransmitter transmission.
  • Intracellular signaling pathways (e.g., calcium, cyclic AMP) are also targets.

Conclusions:

  • Neurobiologically informed approaches offer a more precise strategy for developing new psychotropic medications.
  • This paradigm shift promises more effective treatments for anxiety and depression with potentially fewer side effects.

Related Experiment Videos